Emerging Company Showcase

Meet The Emerging Company Showcase Speakers

 

  • Ophtec

    IMO Instituto de Microcirugía Ocular

    Ophtec

    IMO Instituto de Microcirugía Ocular

    CORRECTING PRESBYOPIA IN YOUNG PATIENTS WITH THE PHAKIC ARTIPLUS LENS

  • Eric Donnenfeld

    LensGen, Irvine, United States

    Eric Donnenfeld

    LensGen, Irvine, United States

    LENSGEN – A SUPERIOR IOL SOLUTION FOR TREATING PRESBYOPIA

  • J. Fernandez

    Olleyes, Summit, United States

    J. Fernandez

    Olleyes, Summit, United States

    OLLEYES VISUALL: A NOVEL VIRTUAL REALITY PLATFORM IN GLAUCOMA CARE

  • N. Israeli

    Sanoculis Ltd., Kiryat Ono, Israel

    N. Israeli

    Sanoculis Ltd., Kiryat Ono, Israel

    MIMS: STENT-LESS, SIMPLE AND FAST GLAUCOMA SURGERY

  • O. La Schiazza

    DEZIMAL GmbH, Vienna, Austria

    O. La Schiazza

    DEZIMAL GmbH, Vienna, Austria

    HOW DO I SEE AFTER A REFRACTIVE LENS EXCHANGE? – EXPERIENCE YOUR FUTURE IOL VISION PRIOR TO IMPLANTATION

  • R. Lewis

    Vialase, Aliso Viejo, California, United States

    R. Lewis

    Vialase, Aliso Viejo, California, United States

    VIALASE DESIGNING AN IMAGE GUIDED FEMTOSECOND LASER FOR GLAUCOMA TREATMENT

  • S. Marcos

    2EyesVision, Madrid, Spain / University of Rochester, Rochester, United States

    S. Marcos

    2EyesVision, Madrid, Spain / University of Rochester, Rochester, United States

    MULTIFOCAL IOLS SEE-THROUGH SIMULATOR – ENHANCING THE PATIENT EXPERIENCE WITH A TAILORED IOL SELECTION

  • M. Pande

    CustomLens AI, North Ferriby, United Kingdom

    M. Pande

    CustomLens AI, North Ferriby, United Kingdom

    CUSTOMLENS AI: PREMIUM VISION OUTCOMES MADE EASY AN EXPERT SYSTEM FOR POWERING THE ADOPTION OF REFRACTIVE CATARACT SURGERY

  • N. Shimoni

    EyeMed Technologies Ltd., Or Yehuda, Israel

    N. Shimoni

    EyeMed Technologies Ltd., Or Yehuda, Israel

    INNOVATIVE POSTOPERATIVE ADJUSTABLE IOL. VALENS IS AN IOL CRADLE SYSTEM WITH A POSTOPERATIVE, REPEATABLE, ADJUSTABLE LENS POSITION, WHICH ENABLES NON-INVASIVE REFRACTIVE OPTIMIZATION AFTER LENS IMPLANTATION AND WOUND HEALING

  • A. Singh

    W. L. Gore & Associates, Elkton, United States

    A. Singh

    W. L. Gore & Associates, Elkton, United States

    DEVELOPMENT OF A NOVEL GORE SYNTHETIC CORNEA DEVICE

  • D. Stephenson

    Stephenson Eye Associates, Venice / Atia Vision, Campbell, United States

    D. Stephenson

    Stephenson Eye Associates, Venice / Atia Vision, Campbell, United States

    ATIA VISION AND THE OMNIVU MODULAR, SHAPE-CHANGING INTRAOCULAR LENS

  • M. Webb

    Epion Therapeutics, Burlington, United States

    M. Webb

    Epion Therapeutics, Burlington, United States

    EPISMART, TRUE EPI-ON CORNEAL CROSS-LINKING FOR KERATOCONUS

The call for emerging company showcase applications is now closed. Thank you for your applications.

The goal is to have emerging technologies presented to a large ophthalmic audience of doctors and industry to accelerate market introductions. Presentations have been reviewed and discussed with a panel of ESCRS doctor leadership and key industry leads.

Presenting company applications have been reviewed by the ESCRS iNovation® Day Programme Committee, that includes the key leadership of the ESCRS organisation. The fee to present is €2,250.00.

Submissions are now closed and selections were announced in July.

View the ESCRS iNovation® Day 2022 Showcase Presentations
Learn more about the ESCRS iNovation® Day 2023 Sponsorship Opportunities